🕒 Wednesday 28 January 2026 Wed, 28 Jan 2026

Next Science Limited is set to distribute approximately A$0.145 per share following the sale of its assets to OSARTIS GmbH, marking a significant step towards winding down its operations.

Bioxyne Limited has reported a record $17.2 million in quarterly revenue, driven by strong growth in its cannabis and psychedelics segments, alongside strategic international expansions including a Frankfurt dual listing and new manufacturing agreements.

Dubber Corporation Limited has signed a significant five-year contract with a major North American communications provider, while trimming costs and targeting operating cashflow breakeven in FY26.

Enegex Limited has reported promising gold exploration results in Côte d’Ivoire and Western Australia, supported by a $5 million capital raise and strategic board appointments.

American Tungsten & Antimony Ltd has acquired the Dutch Mountain Tungsten Project and its fully permitted processing facility in Utah, positioning itself to accelerate tungsten production in the US by bypassing lengthy federal permitting.

Altitude Minerals has bolstered its exploration portfolio with strategic acquisitions in Nevada and New South Wales, commencing extensive drilling programs while maintaining a solid cash position of $1.9 million.

Stockland announces a 9-cent unfranked dividend for the half-year ending December 2025, alongside a Dividend Reinvestment Plan priced at $5.47 per security. The DRP offers investors a 1% discount and new securities issued will rank equally from the issue date.

Scalare Partners reported a remarkable 231% revenue increase in Q2 FY26, driven by full integration of recent acquisitions and new ecosystem initiatives. The company also turned operating cashflow positive, signalling strong momentum ahead.

Greatland Resources capped off 2025 with robust gold and copper production at Telfer, generating $406 million in operating cash flow, while its Havieron feasibility study confirmed a world-class, low-cost gold-copper mine with a $4.2 billion pre-tax NPV.

Develop Global Limited reports strong December quarter progress with Woodlawn mine commissioning on track, a major contract win, and a significant value uplift at Sulphur Springs ahead of a mid-2026 investment decision.

Ragusa Minerals has raised $600,000 through a private placement to fund exploration at its Purple Pansy Manganese-Gold Project in Arizona, supported strongly by existing shareholders.

LTR Pharma has marked a key milestone with over 1,000 SPONTAN prescriptions under Australia’s Special Access Scheme and is advancing clinical trials and US market preparations for its erectile dysfunction treatments.

Ampol Limited reports a robust fourth quarter Lytton Refiner Margin of US$15.14 per barrel, underpinning a strong preliminary FY25 earnings update with an expected EBIT of approximately $945 million.

Control Bionics has raised $3.8 million to fuel growth, forged a key distribution deal with Tobii, and integrated with Apple’s BCI protocol, while advancing its NeuroStrip and NeuroBounce platforms.

Develop Global Limited reported a positive operating cash flow of AUD 18.8 million for the December 2025 quarter, maintaining robust liquidity despite significant investing and financing cash outflows.

Rapid Critical Metals has launched a comprehensive scoping study for its NSW silver projects, backed by promising drilling results and advanced ore-sorting technology.

St George Mining has appointed a top Washington DC government relations firm to deepen its engagement with US agencies, advancing its Araxá rare earths project amid growing US efforts to secure critical mineral supply chains in the Western Hemisphere.

29Metals Limited has initiated a fully underwritten $150 million entitlement offer at $0.40 per share, aiming to bolster its growth projects and operational recovery following seismic disruptions. The retail offer opens on 28 January and closes on 11 February 2026.

Advanced Metals has ramped up its drilling programs in Mexico and Australia, backed by a $13 million capital raise and strengthened leadership, positioning itself for significant resource growth in 2026.

Bioxyne Limited has posted a record $17.2 million in quarterly revenue for Q2 FY26, driven by strong growth in its cannabis and psychedelics segments alongside strategic international expansions.

Tetratherix Limited (ASX, TTX) reports significant progress in clinical trials, strategic partnerships, and manufacturing capacity, positioning itself for near-term commercialisation and sustained innovation.

Coronado Global Resources reported a solid FY25 with increased saleable production and reduced mining costs, underpinned by key expansions and refinancing deals that set the stage for stronger cash flow in 2026.

Ore Resources Ltd has reported significant high-grade gold intercepts at its Miriam Project, extending mineralisation at Forrest to 850 metres. The company also secured binding options to acquire the Randalls Gold Project and raised A$7.5 million to fund its ambitious 2026 exploration plans.

Following its December 2025 ASX debut and a successful IPO, Saluda Medical reports robust global revenue growth and expands its US sales force, prompting an upward revision of its FY26 revenue guidance.